Get the latest news, insights, and market updates on ETON (Eton Pharmaceuticals, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
February 2026's Top Growth Companies With Insider Influence
As February 2026 begins, U.S. stock markets have surged, with major indexes like the Dow Jones and S&P 500 showing strong gains amid positive economic developments such as a new trade deal with India. In this vibrant market environment, growth companies with high insider ownership can offer unique insights into potential success stories, as insiders' vested interests often align closely with shareholder value creation. Feb 19, 2026 - $ETON
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
Product is currently under review with the FDAPotential approval and launch mid-2026 DEER PARK, Ill., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the licensing of U.S. marketing rights to an ultra-rare disease product candidate. Once approved, the product is expected to be the first and only generic alternative to a Feb 2, 2026 - $ETON
Insider Favorites: 3 Growth Stocks With Strong Ownership
In the midst of geopolitical tensions and market volatility, as seen with recent tariff threats impacting major indices, investors are increasingly seeking stability in assets with strong fundamentals. In such uncertain times, growth companies with high insider ownership can be particularly appealing, as they often signal confidence from those closest to the company's operations and future prospects. Jan 21, 2026 - $ETON
Highlighting December 2025's Growth Leaders With Insider Ownership
As the United States stock market grapples with concerns over an AI bubble, technology shares have been under pressure, causing declines in major indices like the Nasdaq and Dow Jones Industrial Average. In such a volatile environment, companies with strong growth potential and high insider ownership can offer investors a sense of stability and alignment of interests between management and shareholders. Dec 15, 2025 - $ETON
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team, will host a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in NYC as follows: DATE: Thursday, December 4, 2025 TIME: 9:30AM ETLOCATION: Lotte New York Palace To sched Nov 24, 2025 - $ETON
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host 1x1 meetings at the 16th Annual Craig-Hallum Alpha Select Conference being held November 18, 2025 in New York, NY. To schedule a 1x1 meeting with the Company, please contact your Craig-Hallu Nov 12, 2025 - $ETON
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
Q3 2025 product sales of $22.5 million, representing 129% growth over Q3 2024 and 19th straight quarter of sequential product sales growthQ3 2025 basic and fully diluted GAAP EPS of $(0.07), non-GAAP fully diluted EPS of $0.04, and Adjusted EBITDA of $2.9 millionET-600 NDA accepted for review, assigned PDUFA date of February 25, 2026GALZIN® launch ahead of plan; exceeded previous year-end target of 200 active patientsHeld positive FDA meeting clarifying pathway to KHINDIVI™ label expansionSubmit Nov 6, 2025 - $ETON
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple